Back to search

Belgium· BE-AMP-SAM097142-00

Minims Oxybuprocaine Chlorhydrate 4 mg/ml

A oxybuprocaine product containing oxybuprocaine hydrochloride, registered in Belgium by Bausch + Lomb Ireland. The same ATC class is registered in 11 of our 19 countries.

ATC S01HA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMinims Oxybuprocaine Chlorhydrate 4 m…ATCS01HA02REGISTER NO.BE-AMP-SAM097142-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Oxybuprocaine is registered in 11 of 19 countries.

Countries holding a registration under ATC S01HA02 (oxybuprocaine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Oxybuprocaine · ATC S01HA02

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Oxybuprocaine Hydrochloride
Manufacturer
Bausch + Lomb Ireland
Country
Belgium (BE)
ATC code
S01HA02
ATC class
Oxybuprocaine
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0025916

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

40 interactions on record for oxybuprocaine.

Graded by severity as the source publishes them — 40 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Oxybuprocaine · interactions on record

40 records

  • 40 moderate

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • SulfamethizoleB05CA04moderate
  • LidocaineC01BB01moderate
  • Glyceryl trinitrateC01DA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxybuprocaine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxybuprocaine products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Benoxinat Zur Anästhesie In Der Oto-Rhino-Laryngologie, Novain
  • Bulgaria · Бенокси
  • Czechia · Benoxi, Oxybuprocaine Olikla
  • Germany · Conjuncain® Edo®, Novesine
  • Denmark · Oftasen, Oxybuprocainhydrochlorid Agepha
  • Estonia · Novain
  • Spain · Oxibuprocaína Hidrocloruro Agepha
  • Finland · Minims, Obupro 4 Mg/Ml Silmätipat, Liuos
  • France · Cebesine, Chlorhydrate D’oxybuprocaine Thea
  • United Kingdom (Northern Ireland) · Oxybuprocaine Hydrochloride Alfa Intes
  • Croatia · Ophtesia
  • Hungary · Humacain, Oxybuprocaine Hydrochloride Agepha
  • Ireland · Oxybuprocaine Agepha
  • Iceland · Novain
  • Italy · Benoxinato Cloridrato Intes, Novesina
  • Lithuania · Novain
  • Luxembourg · Conjuncain Edo, Minims
  • Latvia · Oxybuprocaine Hydrochloride Agepha 4 Mg/Ml
  • Netherlands · Minims, Monofree
  • Norway · Obupro, Oxibuprokain Minims Bausch + Lomb Ireland Limited
  • Poland · Novain, 4 Mg/Ml,
  • Portugal · Anestocil, Novain 4 Mg/Ml Colírio,
  • Romania · Benoxi, Oftacain
  • Sweden · Novain, Oxibuprokain Bausch & Lomb
  • Slovakia · Benoxi, Oxybuprocaine Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dc9529c2-64ca-4b4e-9781-b5414204e688
GET /v1/drugs/dc9529c2-64ca-4b4e-9781-b5414204e688?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Eye drops, solution",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Minims Oxybuprocaine Chlorhydrate 4 mg/ml",
  "name_fr": "Minims Oxybuprocaine Chlorhydrate 4 mg/ml",
  "name_nl": "Minims Oxybuprocaine Chlorhydrate 4 mg/ml",
  "amp_code": "SAM097142-00",
  "strengths": [
    "4.0000",
    "3.5800"
  ],
  "pack_count": 3,
  "substances": [
    "Oxybuprocaine Hydrochloride",
    "Oxybuprocaine"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Oxybuprocaine",
  "authorisation_numbers": [
    "BE097142"
  ]
}

See everything about oxybuprocaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.